Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP430045.RAVYDC9lQLqDKDrU-hCt6lqFMxCVYA1fmTi8a4Sp2faE4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP430045.RAVYDC9lQLqDKDrU-hCt6lqFMxCVYA1fmTi8a4Sp2faE4130_assertion type Assertion NP430045.RAVYDC9lQLqDKDrU-hCt6lqFMxCVYA1fmTi8a4Sp2faE4130_head.
- NP430045.RAVYDC9lQLqDKDrU-hCt6lqFMxCVYA1fmTi8a4Sp2faE4130_assertion description "[Clinical studies in patients with solid tumors using a second-generation antisense oligonucleotide (GEM 231) targeted against protein kinase A type I.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP430045.RAVYDC9lQLqDKDrU-hCt6lqFMxCVYA1fmTi8a4Sp2faE4130_provenance.
- NP430045.RAVYDC9lQLqDKDrU-hCt6lqFMxCVYA1fmTi8a4Sp2faE4130_assertion evidence source_evidence_literature NP430045.RAVYDC9lQLqDKDrU-hCt6lqFMxCVYA1fmTi8a4Sp2faE4130_provenance.
- NP430045.RAVYDC9lQLqDKDrU-hCt6lqFMxCVYA1fmTi8a4Sp2faE4130_assertion SIO_000772 14751840 NP430045.RAVYDC9lQLqDKDrU-hCt6lqFMxCVYA1fmTi8a4Sp2faE4130_provenance.
- NP430045.RAVYDC9lQLqDKDrU-hCt6lqFMxCVYA1fmTi8a4Sp2faE4130_assertion wasDerivedFrom befree-2016 NP430045.RAVYDC9lQLqDKDrU-hCt6lqFMxCVYA1fmTi8a4Sp2faE4130_provenance.
- NP430045.RAVYDC9lQLqDKDrU-hCt6lqFMxCVYA1fmTi8a4Sp2faE4130_assertion wasGeneratedBy ECO_0000203 NP430045.RAVYDC9lQLqDKDrU-hCt6lqFMxCVYA1fmTi8a4Sp2faE4130_provenance.